EA201270817A1 - Соединения, обладающие антибактериальной активностью в отношении clostridium - Google Patents

Соединения, обладающие антибактериальной активностью в отношении clostridium

Info

Publication number
EA201270817A1
EA201270817A1 EA201270817A EA201270817A EA201270817A1 EA 201270817 A1 EA201270817 A1 EA 201270817A1 EA 201270817 A EA201270817 A EA 201270817A EA 201270817 A EA201270817 A EA 201270817A EA 201270817 A1 EA201270817 A1 EA 201270817A1
Authority
EA
Eurasian Patent Office
Prior art keywords
antibacterial activity
clostridium
compositions
respect
compounds
Prior art date
Application number
EA201270817A
Other languages
English (en)
Other versions
EA021567B1 (ru
Inventor
Жером Эмиль Жорж Гийемон
Пьер Жан-Мари Бернар Рабуассон
Насер Люни
Original Assignee
Эланко Энимал Хелс Айрлэнд Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эланко Энимал Хелс Айрлэнд Лимитед filed Critical Эланко Энимал Хелс Айрлэнд Лимитед
Publication of EA201270817A1 publication Critical patent/EA201270817A1/ru
Publication of EA021567B1 publication Critical patent/EA021567B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Настоящее изобретение относится к новым соединениям формулы (I), обладающим антибактериальной активностью в отношении бактерий Clostridium,в частности Clostridium perfringens,фармацевтическим композициям, содержащим указанные соединения, и химическим способам получения указанных соединений.
EA201270817A 2010-08-04 2011-08-04 Соединения, обладающие антибактериальной активностью в отношении clostridium EA021567B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10171842 2010-08-04
PCT/EP2011/063434 WO2012017030A1 (en) 2010-08-04 2011-08-04 Compounds with antibacterial activity against clostridium

Publications (2)

Publication Number Publication Date
EA201270817A1 true EA201270817A1 (ru) 2013-05-30
EA021567B1 EA021567B1 (ru) 2015-07-30

Family

ID=43125618

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201270817A EA021567B1 (ru) 2010-08-04 2011-08-04 Соединения, обладающие антибактериальной активностью в отношении clostridium

Country Status (28)

Country Link
US (1) US8618100B2 (ru)
EP (1) EP2601193B1 (ru)
JP (1) JP5886285B2 (ru)
KR (1) KR101499368B1 (ru)
CN (1) CN103038234B (ru)
AR (1) AR082472A1 (ru)
AU (1) AU2011287584B2 (ru)
BR (1) BR112013003675A8 (ru)
CA (1) CA2805358C (ru)
CL (1) CL2013000331A1 (ru)
CO (1) CO6680629A2 (ru)
CY (1) CY1116238T1 (ru)
DK (1) DK2601193T3 (ru)
EA (1) EA021567B1 (ru)
ES (1) ES2538998T3 (ru)
HK (1) HK1180690A1 (ru)
HR (1) HRP20150467T1 (ru)
ME (1) ME02061B (ru)
MX (1) MX2013001246A (ru)
NZ (1) NZ605850A (ru)
PL (1) PL2601193T3 (ru)
PT (1) PT2601193E (ru)
RS (1) RS53990B1 (ru)
SG (1) SG187175A1 (ru)
SI (1) SI2601193T1 (ru)
TW (1) TWI498330B (ru)
WO (1) WO2012017030A1 (ru)
ZA (1) ZA201300432B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9079935B2 (en) 2012-08-13 2015-07-14 The Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las Vegas Reducing risk of contracting Clostridium-difficile associated disease
WO2016127102A2 (en) * 2015-02-06 2016-08-11 Ernesto Abel-Santos Inhibiting germination of clostridium perfringens spores to reduce necrotic enteritis
GB201509326D0 (en) 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
KR101769204B1 (ko) * 2015-08-04 2017-08-17 씨제이헬스케어 주식회사 크로마놀 유도체의 신규한 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5247705B2 (ja) * 2006-09-26 2013-07-24 クレストーン・インコーポレーテッド 抗細菌活性を持つ置換チエノピリドン化合物
CA2664588C (en) * 2006-09-26 2014-12-23 Crestone, Inc. Enantiomeric fused-pyridinone compounds with antibacterial activity
US8658670B2 (en) * 2006-09-26 2014-02-25 Crestone, Inc. Methods and compounds for treatment of clostridium based infection

Also Published As

Publication number Publication date
CN103038234B (zh) 2016-02-24
CL2013000331A1 (es) 2013-06-28
BR112013003675A8 (pt) 2017-12-26
SI2601193T1 (sl) 2015-05-29
AU2011287584B2 (en) 2014-05-01
HRP20150467T1 (hr) 2015-06-05
PL2601193T3 (pl) 2015-08-31
CN103038234A (zh) 2013-04-10
EP2601193B1 (en) 2015-03-11
TWI498330B (zh) 2015-09-01
WO2012017030A1 (en) 2012-02-09
EP2601193A1 (en) 2013-06-12
ZA201300432B (en) 2014-08-27
JP5886285B2 (ja) 2016-03-16
DK2601193T3 (en) 2015-03-23
MX2013001246A (es) 2013-03-21
BR112013003675A2 (pt) 2016-09-06
EA021567B1 (ru) 2015-07-30
US20130109694A1 (en) 2013-05-02
KR20130033440A (ko) 2013-04-03
SG187175A1 (en) 2013-02-28
CY1116238T1 (el) 2017-02-08
ES2538998T3 (es) 2015-06-25
ME02061B (me) 2015-05-20
HK1180690A1 (en) 2013-10-25
TW201211048A (en) 2012-03-16
CA2805358C (en) 2016-02-16
AU2011287584A1 (en) 2013-02-07
CA2805358A1 (en) 2012-02-09
RS53990B1 (en) 2015-10-30
CO6680629A2 (es) 2013-05-31
PT2601193E (pt) 2015-05-18
KR101499368B1 (ko) 2015-03-05
NZ605850A (en) 2014-07-25
AR082472A1 (es) 2012-12-12
US8618100B2 (en) 2013-12-31
JP2013532714A (ja) 2013-08-19

Similar Documents

Publication Publication Date Title
EA201500652A1 (ru) Дифторметилникотиновые инданилкарбоксамиды
PH12014502697A1 (en) New diazaspirocycloalkane and azaspirocycloalkane
EA201170772A1 (ru) Органические соединения
UA114087C2 (xx) Похідні піридину
EA201390274A1 (ru) Борсодержащие малые молекулы
EA201400412A1 (ru) ЗАМЕЩЕННЫЕ БЕНЗИЛИНДАЗОЛЫ ДЛЯ ПРИМЕНЕНИЯ В КАЧЕСТВЕ ИНГИБИТОРОВ Bub1 КИНАЗЫ ДЛЯ ЛЕЧЕНИЯ ГИПЕРПРОЛИФЕРАТИВНЫХ ЗАБОЛЕВАНИЙ
EA201400833A1 (ru) Новые индолизиновые соединения, способ их получения и фармацевтические композиции, содержащие их
EA201300146A1 (ru) ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ МОДУЛЯТОРА c-МЕТ
MA33939B1 (fr) 5-alcynyl-pyrimidines
UA111626C2 (uk) Похідні дигідрохінолін-2-ону
EA201400771A1 (ru) Новые производные азетидина, фармацевтические композиции и их применение
EA201590887A1 (ru) Композиция
UA111744C2 (uk) ЗАМІЩЕНІ ПІРИДОПІРАЗИНИ ЯК ІНГІБІТОРИ Syk
EA201490846A1 (ru) Новые производные арилхинолина
EA201490435A1 (ru) Антибактериальные 3,4-дигидро-1н-[1,8]нафтиридиноны, замещенные пиперидинилом
UA111210C2 (uk) Антибактеріальні 3,4-дигідро-1h-[1,8]нафтиридинони, заміщені циклопента[c]піролом
MX2012008141A (es) Compuestos y metodos.
PH12015501175A1 (en) Substituted pyridopyrazines as syk inhibitors
EA201490436A1 (ru) Антибактериальные 3,4-дигидро-1н-[1,8]нафтиридиноны, замещенные гомопиперидинилом
EA201590339A1 (ru) Новые антибактериальные соединения
EA201590331A1 (ru) Новые антибактериальные соединения
EA201270817A1 (ru) Соединения, обладающие антибактериальной активностью в отношении clostridium
EA201591192A1 (ru) Антибактериальные соединения
TR201009166A2 (tr) Sefdinir içeren farmasötik bileşim için üretim yöntemi
EA201101703A1 (ru) 17β-АЛКИЛ-17α-ОКСИЭСТРАТРИЕНЫ

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU